Improvement of donor human retinal ganglion cell survival through modulation of microglia

Stem cell-derived retinal ganglion cell transplantation therapy offers a promising avenue for restoring vision in patients with significant retinal ganglion cell (RGC) loss. The major challenge in this therapeutic approach is ensuring the survival of transplanted donor human retinal ganglion cells (hRGCs) within the host retina. Here, we demonstrated the pivotal role of host retinal microglia/macrophages in the rejection, acceptance and survival of donor cells.

To explore the interaction between microglia and RGCs and to identify the targets for potential treatment, we utilized our previously assembled set of single-cell atlases for mouse retina. The downstream analysis has highlighted a phagocytosis among other known pathways involved in microglia activation, neuroinflammation and host retinal ganglion cell damage. We showed the possibility to improve the survival of donor human stem cell-derived retinal ganglion cells through modulation of the host retinal microglia.

Pretreatment of donor human retinal ganglion cells with annexin V before transplantation leads to a 2.5-fold increase in donor cell short-term survival and axon outgrowth targeting optic nerve head (ONH). In addition, pretreatment of donor hRGCs with annexin V and soluble Fas ligand (sFasL) improves the retention of donor hRGCs within the retina following transplantation. This work was supported by NEI/NIH U24 (PB), Gilbert Family Foundation (PB), VRP FTTSA VR220053 (PB), Gilbert Family Foundation (PB).

The authors would like to thank Dr. Don Zack for providing the Brn3b-tdTomato hESCs. NEI/NIH U24 (PB), GFF (PB), DoD FTTSA VRP (PB), Gilbert Family Foundation (PB).

Malechka and Monichan Hayes Phay contributed equally to this work. Department of Ophthalmology, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, 02114, USA Volha V. Malechka, Monichan Hayes Phay, Josy Augustine, Emil Kriukov, John Dayron Rivera, Meredith Gregory-Ksander & Petr Baranov Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, UK Center for Systems Biology and Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA The authors declare no competing interests.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Below is the link to the electronic supplementary material. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.